https://www.businesswire.com/news/home/20230620687501/en/Biolinq-and-Taisho-Pharmaceutical-Announce-Strategic-Collaboration-and-Exclusive-License-Agreement-in-Japan
Biolinq and Taisho Pharmaceutical Announce Strategic Collaboration and Exclusive License Agreement...
Biolinq Incorporated, a medtech company that is developing novel biosensing technologies, has signed an exclusive license agreement with Taisho Pharmaceutica...
taisho pharmaceuticalstrategic collaborationexclusive licenseannounceagreement
https://www.epo.org/de/boards-of-appeal/decisions/t910434eu1
T 0434/91 (Prostaglandin E1 emulsion/TAISHO PHARMACEUTICAL) vom 04.03.1993
prostaglandin e1